Your account is not claimed yet. You can sign up with ORCID to claim your account.

Fabio Luigi Massimo Ricciardolo (Fabio L M Ricciardolo, Fabio Lm Ricciardolo)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 16

Top Venues

Biomedicines

European respiratory review : an official journal of the European Respiratory Society

Science translational medicine

Journal of personalized medicine

Università degli Studi di Torino

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Università degli Studi di Torino

Italy

Professore Associato già Ricercatore Universitario :: Dipartimento di Scienze Cliniche e Biologiche

Publications

Giuseppe Guida, Francesca Bertolini, Vitina Carriero, Stefano Levra, Andrea Elio Sprio, Martina Sciolla, Giulia Orpheu, Elisa Arrigo, Stefano Pizzimenti, Riccardo Castagnoli, Fabio Luigi Massimo Ricciardolo
Reliability of Total Serum IgE Levels to Define Type 2 High and Low Asthma Phenotypes. Journal of clinical medicine 12 (17) (2023)
Antonino Di Stefano, Umberto Rosani, Stefano Levra, Isabella Gnemmi, Paola Brun, Mauro Maniscalco, Silvestro Ennio D'Anna, Vitina Carriero, Francesca Bertolini, Fabio Luigi Massimo Ricciardolo
Bone Morphogenic Proteins and Their Antagonists in the Lower Airways of Stable COPD Patients. Biology 12 (10) (2023)
Augusta S Beech, Andrea Portacci, Beatrice Herrero-Cortina, Alexander G Mathioudakis, Carolina Gotera, Lena Uller, Fabio Luigi Massimo Ricciardolo, Pavol Pobeha, Robert J Snelgrove, Gerrit J Braunstahl, Apostolos Bossios, Omar Usmani, Sachin Ananth
ERS International Congress 2022: highlights from the Airway Diseases Assembly. ERJ open research 9 (3) (2023)
Fabio Luigi Massimo Ricciardolo, Giuseppe Guida, Francesca Bertolini, Antonino Di Stefano, Vitina Carriero
Phenotype overlap in the natural history of asthma. European respiratory review : an official journal of the European Respiratory Society 32 (168) (2023)
Fabio Luigi Massimo Ricciardolo, Giuseppe Guida, Francesca Bertolini, Antonino Di Stefano, Vitina Carriero
Phenotype overlap in the natural history of asthma. European respiratory review : an official journal of the European Respiratory Society 32 (168) (2023)
Fabio Luigi Massimo Ricciardolo, Giuseppe Guida, Francesca Bertolini, Antonino Di Stefano, Vitina Carriero
Phenotype overlap in the natural history of asthma. European respiratory review : an official journal of the European Respiratory Society 32 (168) (2023)
Stefano Levra, Giuseppe Guida, Andrea Elio Sprio, Flavio Crosa, Paolo Carlo Ghio, Francesca Bertolini, Vitina Carriero, Carlo Albera, Fabio Luigi Massimo Ricciardolo
Long-Term Safety of Antifibrotic Drugs in IPF: A Real-World Experience. Biomedicines 10 (12) (2022)
Stefano Levra, Giuseppe Guida, Andrea Elio Sprio, Flavio Crosa, Paolo Carlo Ghio, Francesca Bertolini, Vitina Carriero, Carlo Albera, Fabio Luigi Massimo Ricciardolo
Long-Term Safety of Antifibrotic Drugs in IPF: A Real-World Experience. Biomedicines 10 (12) (2022)
Fabio Luigi Massimo Ricciardolo, Andrea Elio Sprio, Andrea Baroso, Fabio Gallo, Elisa Riccardi, Francesca Bertolini, Vitina Carriero, Elisa Arrigo, Riccardo Castagnoli
Characterization of T2-Low and T2-High Asthma Phenotypes in Real-Life. Biomedicines 9 (11) (2021)
Gabriele Pollara, Carolin T Turner, Joshua Rosenheim, Aneesh Chandran, Lucy C K Bell, Ayesha Khan, Amit A Patel, Luis Felipe Peralta, Anna Folino, Ayse U Akarca, Cristina Venturini, Tina Baker, Simone Ecker, Fabio Luigi Massimo Ricciardolo, Teresa Marafioti, Cesar Ugarte-Gil, David A J Moore, Benjamin M Chain, Gillian S Tomlinson, Mahdad Noursadeghi
Exaggerated IL-17A activity in human in vivo recall responses discriminates active tuberculosis from latent infection and cured disease. Science translational medicine 13 (592) (2021)
Fabio Luigi Massimo Ricciardolo, Francesca Bertolini, Vitina Carriero
The Role of Dupilumab in Severe Asthma. Biomedicines 9 (9) (2021)
Fabio Luigi Massimo Ricciardolo, Vitina Carriero, Francesca Bertolini
Which Therapy for Non-Type(T)2/T2-Low Asthma. Journal of personalized medicine 12 (1) (2021)
Angela Marina Montalbano, Giuseppina Chiappara, Giusy Daniela Albano, Maria Ferraro, Caterina Di Sano, Patrizio Vitulo, Loredana Pipitone, Fabio Luigi Massimo Ricciardolo, Giulia Anzalone, Mirella Profita
Expression/Activation of PAR-1 in Airway Epithelial Cells of COPD Patients: Ex Vivo/In Vitro Study. International journal of molecular sciences 22 (19) (2021)
Richard Y Kim, Krishna P Sunkara, Ken R Bracke, Andrew G Jarnicki, Chantal Donovan, Alan Chen-Yu Hsu, Antonio Ieni, Emma Louise Beckett, Izabela Galvão, Sara Wijnant, Fabio Luigi Massimo Ricciardolo, Antonino Di Stefano, Tatt Jhong Haw, Gang Liu, Angela L Ferguson, Umaimainthan Palendira, Peter A B Wark, Griet Conickx, Pieter Mestdagh, Guy G O Brusselle, Gaetano Caramori, Paul S Foster, Jay C Horvat, Philip Michael Hansbro
A microRNA-21-mediated SATB1/S100A9/NF-κB axis promotes chronic obstructive pulmonary disease pathogenesis. Science translational medicine 13 (621) (2021)
Francesca Bertolini, Vitina Carriero, Michela Bullone, Andrea Elio Sprio, Ilaria Defilippi, Valentina Sorbello, Federica Gani, Antonino Di Stefano, Fabio Luigi Massimo Ricciardolo
Correlation of matrix-related airway remodeling and bradykinin B1 receptor expression with fixed airflow obstruction in severe asthma. Allergy 76 (6) (2020)
Fabio Luigi Massimo Ricciardolo, Vitina Carriero, Michela Bullone
MicroRNAs as Biomarkers in Corticosteroid-Resistant/Neutrophilic Asthma: Still a Long Way to Go! American journal of respiratory and critical care medicine 202 (1) (2020)

Fabio Luigi Massimo Ricciardolo.css-eqlu8i{font-size:small;padding-left:4px;} (Fabio L M Ricciardolo, Fabio Lm Ricciardolo)

Publication Activity (10 Years)

Top Topics

Top Venues

Fabio Luigi Massimo Ricciardolo (Fabio L M Ricciardolo, Fabio Lm Ricciardolo)